secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2025-02-21T23:59:59+00:00
Accession:  0001100682-25-000014
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Foster buys $1M in CRL stock; COO Girshick buys $250K
---------------------------------------------------------

- CEO James Foster purchased 6,075 shares at avg $165.01 (~$1M); COO Girshick purchased 1,514 shares at avg $164.63 (~$250K) on Feb 20, 2025.
- Both terminated existing Rule 10b5-1 trading plans on Feb 19 to allow purchases without violating Section 16 short-swing profit rules.
- Foster's plan allowed up to 129,721 shares; he sold 25,000 shares under it in Aug 2024. Girshick's plan allowed up to 22,362 shares; no sales occurred.
- Executives cited confidence in strategic direction and long-term growth prospects as reason for open-market purchases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000110068225000014/0001100682-25-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000110068225000014/crl-20250220.htm
  HTML page:      https://secwatch.observer/filing/0001100682-25-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer